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article, it is mentioned that there is a sta-
tistically significant difference, in terms of
mortality, between patients having a docu-
mented infection and the rest of the patients
(23.8% vs 1.2%, P  .001).1 These data,
however, should be interpreted with cau-
tion. When considering the main character-
istics of the study cohort, patients with
infection versus patients without infection
already differ in terms of age and underly-
ing conditions before the onset of infection.
The authors themselves demonstrated clearly
a statistically significant difference con-
cerning left ventricular ejection fraction
(better in the patient group with lower mor-
tality). This cannot be neglected because it
has widely been demonstrated that such
organ dysfunctions are indispensably asso-
ciated with increased mortality.2 Here a
logistic regression model with adjustment
for possible confounding factors, such as
length of hospitalization before infection,
age, and severity of illness, could be used
to assess the potential causative effect of
infection on mortality. With regard to this,
we wonder whether the authors can provide
further details on the rate of patients receiv-
ing appropriate antimicrobial agents. This
has been shown to significantly improve
patient outcome.3-5 Furthermore, with re-
spect to the severity of illness, a certain
estimation by means of, for example,
EuroSCORE could explain possible differ-
ences of outcome measures between both
groups. We would appreciate if Falagas
and colleagues could elaborate on their re-
port, keeping those issues in mind.
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Reply to the Editor:
We appreciate the comments of Vandijck
and colleagues regarding our study.1 They
raised the issue of the potential mortality
attributable to infection in our study group
(patients who underwent off-pump coronary
artery bypass grafting). They consider that
confounding factors, such as age, comorbid-
ity, left ventricular ejection fraction, antimi-
crobial treatment, and EuroSCORE values,
might have led to the observed statistically
significant difference in mortality between
patients with and without microbiologically
documented nosocomial infection.
Our results regarding mortality of patients
who underwent coronary artery bypass graft-
ing are in accordance with the results of pre-
vious studies (a fact that is mentioned in the
discussion section of our article).2,3 For ex-
ample, using data from the US Society of
Thoracic Surgeons National Cardiac Data-
base, Fowler and associates2 showed that pa-
tients with major infection had significantly
higher mortality (17.3% vs 3.0%, P .0001)
and postoperative length of stay of longer
than 14 days (47.0% vs 5.9%, P  .0001)
than patients without infection.
However, we agree with Vandijck and
colleagues that infections are sometimes the
consequence of other postoperative compli-
cations or comorbidity that predispose to in-
fections. It should be emphasized that the
majority of patients (4/7 [57%]) with sternal
wound infection in our cohort had a history
of previous sternotomy or postoperative in-
vasive interventions at the surgical site.
We did not collect data to estimate
EuroSCORE values for the group of patients
who did not have nosocomial infection based
on the design of our study, and these data are
not readily available now to be analyzed.
However, we performed an additional analy-
sis of factors associated with mortality in our
cohort of patients. Variables that were statis-
tically associated (P  .05) with mortality in
the bivariable analysis were entered in a
backward, stepwise, multivariable logistic re-
gression model. This statistical analysis re-
vealed that independent risk factors for death
were urgent operation, anemia (hematocrit,
34%), and low left ventricular ejection
fraction on admission (P .001 for all these
variables).
We also agree with Vandijck and col-
leagues that appropriate antimicrobial
treatment of postoperative infections is es-
sential to improve patient outcome. It has
been shown that inappropriate empirical
therapy is associated with increased mor-
tality, especially among patients with in-
fections caused by multidrug-resistant
bacteria.4 In fact, old antibiotics, such as
polymyxins, have been used recently to
combat some of these infections.5 Two of
21 patients with infection in our cohort
(patients 2 and 17 in Table 3 of our article)1
were infected with multidrug-resistant iso-
lates; these patients did not receive appropri-
ate empirical antimicrobial therapy until the
results of the in vitro susceptibility testing of
the isolated pathogens became available.
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